Glipizide ER 2.5 mg Recall: Failed Dissolution Specs
Amerisource Health Services recalls Glipizide ER 2.5 mg tablets due to failed dissolution specifications. Check your lot number and expiration date.
Use caution until it’s fixed
Failed Dissolution Specifications:
Contact the company
What happened, in plain English
Amerisource Health Services LLC is recalling one lot of Glipizide, Extended-Release Tablets, 2.5 mg because the product failed dissolution specifications. This means the medication may not release or work as intended. The recall affects 2,028 units distributed nationwide in the USA. Read more at govinfonow.com/recall/32358-glipizide-er-2-5-mg-recall-failed-dissolution-specs.
Source Summary by GovInfoNow · govinfonow.com/recall/32358-glipizide-er-2-5-mg-recall-failed-dissolution-specs · Updated October 9, 2026 · FDA enforcement record: FDA #D-0202-2025
Cite this page
“Glipizide ER 2.5 mg Recall: Failed Dissolution Specs.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32358-glipizide-er-2-5-mg-recall-failed-dissolution-specs. Based on FDA recall #D-0202-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0202-2025%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, which is a quality control measure ensuring the drug releases properly over time. If the dissolution fails, the body may not absorb the medication correctly, potentially leading to inadequate blood sugar control.
Who’s affected
Patients taking this specific prescription medication for diabetes management are affected. Individuals who purchased the recalled lot from pharmacies across the United States are at risk of receiving ineffective treatment.
How to tell if you have this one
Check your medication box for Carton NDC 60687-480-21 or Unit Dose NDC 60687-480-11. Verify that the Lot number is 1012910 and the Expiration Date is 04/30/2025. The product is distributed by American Health Packaging in Columbus, Ohio.
- Brand
Amerisource Health Services- Category
Drug
What to do — step by step
Check Your Medication
Verify if your Glipizide tablets match the recalled NDCs, Lot number 1012910, and expiration date 04/30/2025.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine if you have the recalled product and discuss next steps.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Amerisource Health Services recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0202-2025 (December 17, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0202-2025 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.